Cover Image for New Jurisdictions for Longevity & Medical Innovation @ Zuzalu (Public Workshop)

New Jurisdictions for Longevity & Medical Innovation @ Zuzalu (Public Workshop)

No Upcoming Sessions
This series has no upcoming sessions scheduled. Heard something is coming? Check back later!
About Event

This is an event for biohackers, techno-utopians and jurisdictional hoppers, organised by Alex Miloski, Adam Gries and Laurence Ion.

It takes place during the 2-month-long pop-up mini-city called "Zuzalu" in Tivat, Montenegro.

More info about Zuzalu:

Longevity is the defining question of humanity.

However, biotech R&D and commercial use are chronically underfunded and slow, due to legacy regulatory systems that lock in old solutions and create bottlenecks for new ones.

Solutions such as medical reciprocity laws, sunset clauses and right-to-try legislation have the ethical upper hand, but the "Machiavelli Effect" (J. Storrs Hall) is preventing adoption.

However, startup cities and network states, as well as innovation-friendly smaller jurisdictions are promising to change the game.

From medical tourism arbitrage in Mexico, Turkey & Thailand, to clinical research hubs such as Australia, pharma production zones in Uruguay and Costa Rica, as well as polycentric law zones such as Prospera Honduras - innovation is on the horizon.

What jurisdictions hold the most promise to unleash the power of longevity biotechnology? How can scientists and entrepreneurs use them?

Can we build a new jurisdiction and a Longevity Network State?

We'll discuss these questions with the key experts and practitioners in the field.

Day 1, Sunday, April 9, 1:30pm - 7pm (Dome): Why State Power is Needed to Accelerate Longevity and Medical Innovation

1:30 - 2:30pm: Medical Ethics by Niklas Anzinger

2:30 - 3:00pm:Cancer Clinical Trials by Zina Sarif

3:00 - 3:30pm: Why we need Longevity States by Adam Gries

3:30 - 4:30pm: Buy healthcare, not medicine by Robin Hanson

4:30 - 5:00pm: Break

5:00 - 6:00pm: Why the win-lose paradigm is ngmi by Greg Davidson

6:00 - 7:00pm: Breakout sessions

Day 2, Monday, April 10, 12pm - 7pm (Dome): How States and New Jurisdictions can Accelerate Longevity and Medical Innovation

12:00 - 12:45pm: How to start a country by Ademidun Tomiwa

12:45 - 1:30pm: Candidate Longevity States fireside chat with Adam Gries Niklas Anzinger, Alex Miloski and Laurence Ion

1:30 - 2:00pm: Puerto Rico advantages + FDA drawbacks (e.g Aduhelm case study etc) by Sebastian Brunemeier

2:00 - 3:00pm: Lunch

3:00 - 3:30pm: Medical Tourism by Jeff Tang

3:30 - 4:00pm: Clinical Trial Arbitrage in Prospera by Mac Davis

4:00 - 4:15pm: Break

4:15 - 5:00pm: Policy Innovation & Seasteading by Joe Lonsdale

5:00 - 5:30pm: How regulators are hindering medical innovation by Josiah Zayner

5:30 - 6:00pm: Novel gene therapies now by Liz Parrish

6:00 - 7:00pm: Breakout session

Day 3, Tuesday, April 11, 6pm - 9pm (Dome): Pitch day for States and New Jurisdictions for Longevity and Medical Innovation

Following amazing presentations and discussions, we'll be hosting a pitch day on Tuesday from 6 - 9pm @ the Dome to wrap up the New Jurisdictions and States for Longevity and Medical Innovation program!

There are currently 7 proposals/problems to work on. We encourage all participants to leverage today's and tomorrow's breakout sessions to form groups and work on those or come up with brand new ideas:

1. What could a new FDA look like: what’s good about the current model, how to guarantee safety, the need for efficacy trials

2. Common standards for longevity research: we currently don't have a "protocol for longevity research": how to measure aging? what are the biomarkers? Could we run drug trials in parallel across multiple jurisdictions?

3. How to deal with Public relations & moral judgment: strategies to get support from host countries.

4. Intelectual Property: how to fractionalize shares on the outcome of trials.

5. How to leverage data transparency: tradeoffs behind centralized database of records (eg Estonia, Dennmark), creating an “aging bio-bank”.

6. Practical aspects of getting a new jurisdiction off the ground: what’s needed for a jurisdiction to be considered legit? What would an MVP look like? Min requirements?

7. Criteria for selecting the best physical locations: main factors for decision making, current options available, need for permanent relocation?

Criteria: We'll prioritize practical proposals that have a clear path to implementation! We want pitches that can potentially seed ideas for new cities, jurisdictions, network states etc.

Judges: Laurence Ion, Niklas Anzinger, Adam Gries, Michael Harte, Sebastian Brunemeier.

Prize: 1,000 VITA 💛